Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Potentiating Dietary Green Tea Extracts Anti-Tumor Activity of Cisplatin in BALB/c Mice Bearing CT26 Colon Carcinoma

대장암(CT 26) 생쥐에서 녹차추출물 음용에 의한 시스플라틴 항암작용 증강효과

  • 이병래 (조선대학교 의과대학 생화학교실) ;
  • 박평심 (조선대학교 의학연구원)
  • Received : 2012.04.12
  • Accepted : 2012.05.15
  • Published : 2012.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Green tea intake is known to have preventive effects against cancer. In this study, we evaluated the tumor suppressive effects of dietary green tea extracts (GTE) as a modulator on cisplatin in an established colon cancer mouse model. The cisplatin-induced cytotoxicity was determined with cell viability of the mouse colon cancer cell line (CT26) in vitro. The influence of GTE on the anti-tumor activity of cisplatin was evaluated by measuring tumor size with digital calipers in mice bearing CT26 colon carcinomas. The CT26 cell viability decreased to 93% at a $20{\mu}g/mL$ concentration of cisplatin. However, cell viability decreased to 15% with a combination of $20{\mu}g/mL$ cisplatin and GTE ($75{\mu}g/mL$). There were no apparent changes in cisplatin-induced cytotoxicity with GTE and epigallocathechin gallate (EGCG) treatments. Tumor size decreased in dietary GTE combining intra-peritoneal cisplatin-injected tumors bearing mice compared with cisplatin or GTE alone administered to tumor-bearing mice. These experiments showed that dietary GTE has a potentiating effect on the cisplatin anti-tumor activity of an established mice colon cancer model. Therefore, the GTE may be a candidate for modulators in anticancer treatments with cisplatin.

본 실험에서는 녹차추출물이 항암화학요법제의 항암작용 증강제로서의 이용가능성을 추정하기 위하여 광범위 항암화학요법제인 시스플라틴의 항암작용에 미치는 녹차추출물의 영향을 생쥐 대장암세포를 이용하여 관찰한 결과, 생쥐대장암세포인 CT26 세포를 배양하여 녹차추출물이나 EGCG을 투여하면 시스플라틴에 의한 세포독성이 증가되었는데, 시스플라틴의 세포독성에 미치는 EGCG와 녹차추출물의 효과 차이는 없었다. 생쥐에 CT26 세포를 주사하여 유발된 종양의 성장이 시스플라틴군보다 시스플라틴+녹차추출물 병합 투여로 현저히 감소되었다. 이상의 결과 녹차추출물은 화학요법제인 시스플라틴과 병합 투여할 경우 화학요법제 단독 투여 시보다 대장암 세포의 활성도 감소가 더 크고, 생쥐대장암의 크기를 감소시키는 작용도 더 크기 때문에 녹차추출물을 화학요법제와 병행투여하면 항암치료 효과가 증가될 것으로 생각된다. 따라서 녹차추출물은 항암화학요법제에 의한 암치료에서 치료효과를 증강시킬 수 있는 보조제로서 이용될 수 있을 것으로 기대되며, 이러한 효과를 입증하기 위한 더 많은 연구가 있어야 할 것으로 사료된다.

Keywords

References

  1. Kazi A, Smith DM, Daniel K, Zhong S, Gupta P, Bosley ME. 2002. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention. In Vivo 16: 397-403.
  2. Yang CS, Wang X. 2010. Green tea and cancer prevention. Nutr Cancer 62: 931-937. https://doi.org/10.1080/01635581.2010.509536
  3. Lambert JD, Elias RJ. 2010. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501: 65-72. https://doi.org/10.1016/j.abb.2010.06.013
  4. Gupta S, Hussain T, Mukhtar H. 2003. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cells cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410: 177-185. https://doi.org/10.1016/S0003-9861(02)00668-9
  5. Jun YD, Ellis LM. 2001. Inhibition of tumour invasion and angiogenesis by epigallocatechin galltae (EGCG), a major component of green tea. Int J Exp Pathol 82: 309-316.
  6. Matsuyama R, Reddy S, Smith TJ. 2006. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24: 3490-3496. https://doi.org/10.1200/JCO.2005.03.6236
  7. Bartelink H, Schellens JH, Verheij M. 2002. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 38: 216-222. https://doi.org/10.1016/S0959-8049(01)00363-X
  8. Samad A, Sultana Y, Aqil M. 2007. Liposomal drug delivery systems: an update review. Curr Drug Deliv 4: 297-305. https://doi.org/10.2174/156720107782151269
  9. Di Stefano G, Fiume L, Baglioni M, Bolondi L, Busi C, Chieco P, Kratz F, Manaresi F, Pariali M. 2006. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade. Liver Int 26: 726-733. https://doi.org/10.1111/j.1478-3231.2006.01289.x
  10. Kanadaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. 2005. The antitumor activities of flavonoids. In Vivo 19: 895-909.
  11. Sladowski D, Steer SJ, Clothier RH, Balls M. 1993. An improved MTT assay. J Immunol Methods 157: 203-207. https://doi.org/10.1016/0022-1759(93)90088-O
  12. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. 2007. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245: 232-41. https://doi.org/10.1016/j.canlet.2006.01.027
  13. Rao SD, Pagidas K. 2010. Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Anticancer Res 30: 2519-2523.
  14. Silverberg JI, Jagdeo J, Patel M, Siegel D, Brody N. 2011. Green tea extract protects human skin fibroblasts from reactive oxygen species induced necrosis. J Drugs Dermatol 10: 1096-1101.
  15. Crown JP. 2001. The platinum agents: a role in breast cancer treatment? Senmin Oncol 28: 28-37.
  16. Jordan P, Carmo-Fonseca M. 2000. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 57: 1229-1235. https://doi.org/10.1007/PL00000762
  17. Cersosimo RJ. 1993. Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharmacother 27: 438-441.
  18. Chan MM, Soprano KJ, Weinstein K, Fong D. 2006. Epigallocatechin- 3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J Cell Physiol 207: 389-396. https://doi.org/10.1002/jcp.20569

Cited by

  1. Antioxidant and Tyrosinase Inhibitory Effects of the Extract Mixtures of Perilla frutescens, Houttuynia cordata and Camellia sinensis vol.41, pp.2, 2015, https://doi.org/10.15230/SCSK.2015.41.2.173